Reference
Takamori S, et al. Case report: Success of tepotinib therapy in overcoming resistance to osimertinib in a patient with EGFR-mutant lung adenocarcinoma with a potential acquired MET exon 14 skipping mutation. Frontiers in Oncology 12: 13 Oct 2022. Available from: URL: http://www.frontiersin.org/Oncology/about
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1967, 42 (2023). https://doi.org/10.1007/s40278-023-43849-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-43849-6